Keywords: fda, extends, review, sanofi-aventis, anti-obesity, drug, acomplia

FDA extends review of Sanofi-Aventis' anti-obesity drug Acomplia until late July

Article | 19 February 2007

Print This

French drugmaker Sanofi-Aventis says that the US Food and Drug Administration has decided to extend its review of the anti-obesity ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in